Uncategorized
Alexandre is a Principal at Sixty Degree Capital, where he focuses on technology investment in digital infrastructure and transformative software innovation. Prior to joining SDC, he gained valuable experience in the venture capital and innovation space through his work at…
Read More
Brett joined Sixty Degree Capital in May 2021 as a Principal. Prior to joining, Brett worked 7 years in investment in the energy and related technology sector, and completed several acquisitions and private equity investments with a total deal value…
Read More
Robin joined Sixty Degree Capital in November 2019. Prior to joining, Robin worked for Toronto healthcare startups AmacaThera and Focal Healthcare in both business development and fundraising roles. Previously, Robin worked for ApoPharma’s pre-clinical research division as well as also…
Read MoreFunding will support the Phase 2 clinical program of ATI-2173 in HBV Soleus Capital led the round with new major investors RA Capital Management, Adage Capital Management LP, Pontifax and Aisling Capital as well as Altium Capital, Amzak Health, Granite…
Read MoreGAITHERSBURG, Md., April 13, 2021 (GLOBE NEWSWIRE) – – Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it raised $115 million in a Series C financing to advance its pipeline of adaptive and controllable cell therapies. The proceeds…
Read MoreDr. Christopher Heery joins as Chief Medical Officer and Neeraj Teotia joins as Chief Commercial Officer GAITHERSBURG, Md., April 19, 2021 (GLOBE NEWSWIRE) – – Arcellx, a privately held clinical-stage biopharmaceutical company, today announced that it has hired two new…
Read More